← Leaderboards
William Alexander Flavahan
Massachusetts General Hospital
$2,287,045
Attributed
$2,287,045
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.5M · FY2016–24$2M$1.5M$1M$500K$0
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$2,287,045 · 3
By mechanism
DP2$1,507,500 · 1
K22$601,227 · 1
F32$178,318 · 1
Top collaborators
No co-investigators on record.
Most similar at Massachusetts General Hospital
Same institution · by research overlap
- Schahram Akbarian$48,610,378
- Pamela Sklar$31,628,187
- Jonathan L Tilly$11,512,275
- Dori Cousins Woods$687,735
- Russell James Hubbard Ryan$3,033,509
Others in their field
Top investigators on “Malignant Neoplasms”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,074,554,219
- Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
- Richard K. Wilson · Washington University$274,272,747
- Larry Arthur$223,443,122
- Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879
Research focus
Malignant NeoplasmsGenomeMethylationResistanceOncogenesPhenotypeGliomaGenesGenetic TranscriptionHypermethylationEnhancersMutationNeoplastic CellBindingEpigenetic ProcessEnzymesAutomobile DrivingCcctc-Binding FactorFunctional DisorderGeneticGrowthHousekeepingPdgfra GeneSite
Grant awards (7)
Expanding the capabilities of third-generation sequencing for multi-dimensional genome and transcriptome analysis.$1,507,500
DP2 · FY2024 · GM · contact PI
Pathological epigenetic hyper-plasticity promotes acquisition of pro-tumor states in cancer$200,409
K22 · FY2022 · CA · contact PI
Pathological epigenetic hyper-plasticity promotes acquisition of pro-tumor states in cancer$200,409
K22 · FY2021 · CA · contact PI
Pathological epigenetic hyper-plasticity promotes acquisition of pro-tumor states in cancer$200,409
K22 · FY2020 · CA · contact PI
Loss of oncogene insulation drives IDH1 mutant glioma$63,034
F32 · FY2018 · CA · contact PI
Loss of oncogene insulation drives IDH1 mutant glioma$59,166
F32 · FY2017 · CA · contact PI
Loss of oncogene insulation drives IDH1 mutant glioma$56,118
F32 · FY2016 · CA · contact PI